This independent CME/CE activity is supported by educational grants from

Centocor Ortho Biotech Inc.

Genentech BioOncology.
The Advanced Certificate Program in
Breast Cancer Management II
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List

Currently Available

Course Title Curriculum Faculty Release Date
Expert Insight Into: A Human Epidermal Growth Factor Receptor 2 (HER2)-Specific Monoclonal Antibody Plus an Aromatase Inhibitor (AI) Versus an AI Alone for the Treatment of Postmenopausal Women with HER2–Positive/Hormone Receptor-Positive Metastatic Breast Cancer.—Article Review (BC02.13) 1906.06 II Gonzalez-Angulo Feb 2010
Expert Insight Into: High Risk of Recurrence for Breast Cancer Patients with HER2-Positive, Node-Negative Tumors 1 cm. or Smaller—Article Review (BC02.12) 1906.09 II Gonzalez-Angulo Jan 2010
Expert Insight Into: Patterns and Risk Factors Associated with Aromatase Inhibitor-Related Arthralgia Among Breast Cancer Survivors—Article Review (BC02.11) 1906.08 II Burstein Dec 2009
Case Study: Adjuvant Therapy in Hormone-Sensitive, HER2-Negative Breast Cancer—Tx Reporter e-Newsletter (BC02.10) 1907.02 II Burstein
Gradishar		 Nov 2009
Expert Insight Into: Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer —Article Review (BC02.09) 1906.10 II Gradishar Nov 2009
Expert Insight Into: Survival Among Women with Triple Receptor-Negative Breast Cancer and Brain Metastases—Article Review (BC02.08) 1906.07 II Gonzalez-Angulo Oct 2009
Personalizing Breast Cancer Management: Update on Targeted Therapies and Molecular Diagnostics—Audio Interview Series (BC02.07) 1908 II Burstein
Smith		 Oct 2009
Expert Insight Into: Antitumor Activity of PARP Inhibitors in Tumors with BRCA Mutations—Article Review (BC02.06) 1906.05 II Dickler Sep 2009
Case Study: Triple-Negative Breast Cancer—Tx Reporter e-Newsletter (BC02.05) 1907.01 II Burstein
Dickler		 Aug 2009
Expert Insight Into: Association Between Polymorphisms in the VEGF and VEGFR-2 Genes and the Efficacy and Safety of Anti-VEGF Monoclonal Antibody in Patients with Advanced Breast Cancer —Article Review (BC02.04) 1906.04 II Dickler Aug 2009
Expert Insight Into: Whether to Continue HER2-Targeting Therapy After Disease Progression in Advanced Breast Cancer —Article Review (BC02.03) 1906.03 II Dickler Jul 2009
Expert Insight Into: Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer—Article Review (BC02.02) 1906.02 II Gradishar Jul 2009
Expert Insight Into: Endocrine Therapy plus a Bisphosphonate in Premenopausal Breast Cancer—Article Review (BC02.01) 1906.01 II Burstein Jul 2009